RxAll, a startup based in the United States and Nigeria that employs deep technology to provide high-quality medication to patients, has raised USD 3.15 Mn in funding to expand into new countries and further enhance its technology. Launch Africa led the funding round, with participation from SOSV’s HAX and Keisuke Honda’s KSK fund.
RxScanner, RxAll’s exclusive technology, is a portable authenticator that allows patients to double-check their meds. According to the company, the RxScanner can verify the quality of prescription medications in 20 seconds and display the results via mobile apps in real-time. The machine learning model analyzes the sample spectra and generates test results that demonstrate the sample’s identity and quality compared to the reference.
The post Healthtech Startup RxAll Raises USD 3.15 Mn Funding appeared first on WeeTracker.